ישראל - עברית - Ministry of Health

abic marketing ltd, israel - etoposide - תרכיז להכנת תמיסה לאינפוזיה - etoposide 20 mg/ml - etoposide - etoposide - hodgkin's disease. malignant (non-hodgkin's) lymphomas, especially of the histiocytic variety. acute non-lymphocytic leukemia. management of refractory testicular tumors and of small cell lung cancer.

ישראל - עברית - Ministry of Health

novartis israel ltd - etoposide - תרכיז להכנת תמיסה לאינפוזיה - etoposide 20 mg/ml - etoposide - etoposide - small cell lung cancer, resistant non-seminomatous testicular carcinoma, hodgkin's and non-hodgkin's lymphoma, acute myelocytic leukemia.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - felodipine - טבליות עם שחרור נרחב - felodipine 5 mg - felodipine - felodipine - moderade to severe hypertension.angina pectoris.

ישראל - עברית - Ministry of Health

אנה לוטן בעמ - טיפוח עור הפנים

ישראל - עברית - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

ישראל - עברית - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - netupitant; palonosetron as hydrochloride - קפסולות - netupitant 300 mg; palonosetron as hydrochloride 0.50 mg - palonosetron, combinations